Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal –gastric varices
ConclusionsAtez/Bev might be an effective therapeutic option in patients with EGV, when appropriate endoscopic treatment for EGV is performed.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Avastin | Bleeding | Cancer & Oncology | Carcinoma | Endoscopy | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer | Lower Endoscopy | Study | Thrombosis | Upper Endoscopy